Xuesong Han

University of North Carolina at Chapel Hill — United States

Economics, Econometrics and Finance · Social Sciences

55h-index9.6kcitations423works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Economic and Financial Impacts of Cancer(174), Health Systems, Economic Evaluations, Quality of Life(80), Healthcare Policy and Management(60), Global Cancer Incidence and Screening(60), Palliative Care and End-of-Life Issues(33)

Publications422 total

Global burden and between‐country inequalities in Turner syndrome from 1990 to 2021
Acta Obstetricia Et Gynecologica Scandinavica·2025Open Access
County‐level medical debt and treatment initiation among individuals newly diagnosed with cancer
Cancer·2025Open Access
Associations of Partner Cancer History With Access to Care Among Older Adults in the U.S.
American Journal of Preventive Medicine·2025Open Access
Association between Medicaid Expansion and 5-Year Survival among Individuals Diagnosed with Cancer
Cancer Discovery·2025
Transportation barriers, emergency department use, and mortality risk among us adults: a national health interview survey analysis
BMC Public Health·2025· 1 citedOpen Access
Response to Cheng, Palesh, and Hong
JNCI Journal of the National Cancer Institute·2025
Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women.
JCO Oncology Practice·2025
Effects of loneliness on emergency room usage in US cancer survivors.
JCO Oncology Practice·2025
Association of primary care physician rate and cancer incidence and mortality rates in the US.
JCO Oncology Practice·2025
Trends in survival disparity following breast cancer diagnosis by health insurance coverage and race in the US.
JCO Oncology Practice·2025
Medicare Advantage premium, utilization management, and costs for generic abiraterone and imatinib.
JCO Oncology Practice·2025
Disparities in palliative care receipt among young adults newly diagnosed with poor-prognosis cancers.
JCO Oncology Practice·2025
Patients with rare cancers: Diagnosis and treatment patterns in the US.
JCO Oncology Practice·2025
Health-related social needs, biological aging, and long-term mortality risk among a nationally representative cohort of cancer survivors.
JCO Oncology Practice·2025
Growth of enrollment in zero-premium Medicare Advantage (MA) among US counties with high cancer burden.
JCO Oncology Practice·2025
Effective oncology provider networks under Medicare Advantage plans in 2015-2019.
JCO Oncology Practice·2025
Abstract C149: Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty severity, United States, 2021 and 2023
Cancer Epidemiology Biomarkers & Prevention·2025
Changes in cancer diagnoses and stage distribution during the <scp>COVID</scp> ‐19 pandemic in the United States, 2019–2022
International Journal of Cancer·2025
Effects of fermented soybean meal on growth performance, antioxidant capacity and fecal microbiota of piglets
Journal of the Science of Food and Agriculture·2025Open Access
Molecular mechanism and risk assessment of Rhizoctonia solani resistance to the SDHI fungicide isopyrazam
Pesticide Biochemistry and Physiology·2025· 1 cited
page 1 of 22Next →

Frequent Co-authors

K. Robin Yabroff(25), Ahmedin Jemal(25), Zhiyuan Zheng(17), Jingxuan Zhao(13), Gery P. Guy(8), Matthew P. Banegas(8), Donatus U. Ekwueme(8), Chunyu Li(7), Janet S. de Moor(6), Stacey A. Fedewa(6), Letícia Nogueira(6), Amy J. Davidoff(5), Katherine S. Virgo(5), Elizabeth Ward(5), Briseis A. Kilfoy(4), Cairong Zhu(4), Erin E. Kent(4), Chun Chieh Lin(4), Tongzhang Zheng(3), Juan J. Llibre Rodríguez(3)